Literature DB >> 28658011

The Clinical Alliance and Research in Electroconvulsive Therapy Network: An Australian Initiative for Improving Service Delivery of Electroconvulsive Therapy.

Donel M Martin, Verònica Gálvez, Shani Lauf, Vanessa Dong, Stephen A Baily, Narcís Cardoner, Herng N Chan, Don Davidson, Johnson Fam, Nick De Felice, Erika Martinez-Amoros, Titus Mohan, Jothi Ramalingam, Shanthi I Sarma, Phern C Tor, Susan Waite, Colleen K Loo.   

Abstract

OBJECTIVE: There is currently substantial heterogeneity in electroconvulsive therapy (ECT) treatment methods between clinical settings. Understanding how this variation in clinical practice is related to treatment outcomes is essential for optimizing service delivery. The Clinical Alliance and Research in ECT Network is a clinical and research framework with the aims of improving clinical practice, enabling auditing and benchmarking, and facilitating the collection of naturalistic clinical data.
METHODS: The network framework and clinical and treatment variables collected and rationale for the use of particular outcome measures are described. Survey results detailing the use of ECT across initial participating clinical centers were examined.
RESULTS: The data are reported from 18 of 22 participating centers, the majority based in Australia. Melancholic unipolar depression was the most common clinical indication (78%). Right unilateral (44%) and bifrontal (39%) were the most commonly used electrode placements. Eighty one percent of the centers used individual seizure titration for initial dosing.
CONCLUSIONS: There was substantial heterogeneity in the use of ECT between participating centers, indicating that the Network is representative of modern ECT practice. The Clinical Alliance and Research in ECT Network may therefore offer the opportunity to improve service delivery and facilitate the investigation of unresolved research questions pertaining to modern ECT practice.

Entities:  

Mesh:

Year:  2018        PMID: 28658011     DOI: 10.1097/YCT.0000000000000435

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  9 in total

1.  ECT in a time of COVID-19.

Authors:  Phern Chern Tor; Adeline H H Phu; Doris S H Koh; Yee Ming Mok
Journal:  J ECT       Date:  2020-03-31       Impact factor: 3.635

2.  International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic).

Authors:  Takahiro Soda; Declan M McLoughlin; Scott R Clark; Leif Oltedal; Ute Kessler; Jan Haavik; Chad Bousman; Daniel J Smith; Miquel Bioque; Caitlin C Clements; Colleen Loo; Fidel Vila-Rodriguez; Alessandra Minelli; Brian J Mickey; Roumen Milev; Anna R Docherty; Julie Langan Martin; Eric D Achtyes; Volker Arolt; Ronny Redlich; Udo Dannlowski; Narcis Cardoner; Emily Clare; Nick Craddock; Arianna Di Florio; Monika Dmitrzak-Weglarz; Liz Forty; Katherine Gordon-Smith; Mustafa Husain; Wendy M Ingram; Lisa Jones; Ian Jones; Mario Juruena; George Kirov; Mikael Landén; Daniel J Müller; Axel Nordensköld; Erik Pålsson; Meethu Paul; Agnieszka Permoda; Bartlomiej Pliszka; Jamie Rea; Klaus O Schubert; Joshua A Sonnen; Virginia Soria; Will Stageman; Akihiro Takamiya; Mikel Urretavizacaya; Stuart Watson; Maxim Zavorotny; Allan H Young; Eduard Vieta; Janusz K Rybakowski; Massimo Gennarelli; Peter P Zandi; Patrick F Sullivan; Bernhard T Baune
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-12-04       Impact factor: 5.270

3.  The Impact of Electroconvulsive Therapy on Negative Symptoms in Schizophrenia and Their Association with Clinical Outcomes.

Authors:  Xiaowei Tan; Donel Martin; Jimmy Lee; Phern Chern Tor
Journal:  Brain Sci       Date:  2022-04-25

Review 4.  The Neurobiological Basis of Cognitive Side Effects of Electroconvulsive Therapy: A Systematic Review.

Authors:  Adriana Bassa; Teresa Sagués; Daniel Porta-Casteràs; Pilar Serra; Erika Martínez-Amorós; Diego J Palao; Marta Cano; Narcís Cardoner
Journal:  Brain Sci       Date:  2021-09-26

5.  The Impact of COVID-19 on Electroconvulsive Therapy: A Multisite, Retrospective Study From the Clinical Alliance and Research in Electroconvulsive Therapy and Related Treatments Network.

Authors:  Elaine Kwan; Brandon Le; Colleen K Loo; Vanessa Dong; Phern-Chern Tor; Don Davidson; Titus Mohan; Susan Waite; Grace Branjerdporn; Shanthi Sarma; Salam Hussain; Donel M Martin
Journal:  J ECT       Date:  2022-03-01       Impact factor: 3.692

6.  National Network of Depression Centers' Recommendations on Harmonizing Clinical Documentation of Electroconvulsive Therapy.

Authors:  Peter P Zandi; Michael Morreale; Irving M Reti; Daniel F Maixner; William M McDonald; Paresh D Patel; Eric Achtyes; Mahendra T Bhati; Brent R Carr; Susan K Conroy; Mario Cristancho; Marc J Dubin; Andrew Francis; Kara Glazer; Wendy Ingram; Khurshid Khurshid; Shawn M McClintock; Omar F Pinjari; Kevin Reeves; Nelson F Rodriguez; Shirlene Sampson; Stephen J Seiner; Salih Selek; Yvette Sheline; Roy W Smetana; Takahiro Soda; Nicholas T Trapp; Jesse H Wright; Mustafa Husain; Richard D Weiner
Journal:  J ECT       Date:  2022-03-04       Impact factor: 3.692

7.  "ECT should never stop": Exploring the experiences and recommendations of ECT clinical directors and anesthetists about ECT during the COVID-19 pandemic.

Authors:  Grace Branjerdporn; Shanthi Sarma; Laura McCosker; Vanessa Dong; Donel Martin; Colleen Loo
Journal:  Front Psychiatry       Date:  2022-09-14       Impact factor: 5.435

8.  Electroconvulsive Therapy in a Time of Coronavirus Disease.

Authors:  Phern Chern Tor; Adeline H H Phu; Doris S H Koh; Yee Ming Mok
Journal:  J ECT       Date:  2020-06       Impact factor: 3.692

9.  Ventilation Adjustment in ECT During COVID-19: Voluntary Hyperventilation is an Effective Strategy.

Authors:  Aida de Arriba-Arnau; Antònia Dalmau Llitjos; Virginia Soria; Javier Labad; José Manuel Menchón; Mikel Urretavizcaya
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-20       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.